1. Kite Pharma Announces Appointment Of Renowned Cancer Researcher, M.D., To Its Board Of Directors

    Kite Pharma Announces Appointment Of Renowned Cancer Researcher, M.D., To Its Board Of Directors

    Kite Pharma, Inc. today announced that Owen N. Witte, M.D., the founding director of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at the University of California Los Angeles and a renowned cancer researcher, has been appointed to its Board of Directors...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content
  2. Quotes

    1. Owen is a brilliant scientist with a rare combination of understanding for basic research and translational medicine across academia and the biopharmaceutical industry. For well over two decades, Owen has made significant scientific discoveries resulting in medicines that have changed the course of medical history.
    2. Over the past eight years and as Chair of the Scientific Advisory Board, it has been a privilege to witness Kite become a leader in the field of engineered cell therapy for the treatment of cancer.
  3. Topics Mentioned